Primary results, NSABP B-35/NRG Oncology: A clinical trial of anastrozole vs tamoxifen in postmenopausal patients with DCIS undergoing lumpectomy plus radiotherapy A randomized clinical trial

BACKGROUND: NSABP B-35 is a phase III trial comparing anastrozole (A) to tamoxifen (T) for breast cancer-free interval (BCFI), defined as time from randomization to any breast cancer event: local, regional, distant, or contralateral, invasive or DCIS. METHODS: Postmenopausal women with hormone-posit...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Lancet
Hoofdauteurs: Margolese, Richard, Cecchini, Reena S., Julian, Thomas B., Ganz, Patricia A., Costantino, Joseph P., Vallow, Laura A., Albain, Kathy S., Whitworth, Patrick W., Cianfrocca, Mary E., Brufsky, Adam M., Gross, Howard M., Soori, Gamini S., Hopkins, Judith O., Fehrenbacher, Louis, Sturtz, Keren, Wozniak, Timothy F., Seay, Thomas E., Mamounas, Eleftherios P., Wolmark, Norman
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2015
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4792688/
https://ncbi.nlm.nih.gov/pubmed/26686957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(15)01168-X
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items